FRI0358 USAGE OF C-REACTIVE PROTEIN TESTING IN THE DIAGNOSIS AND MONITORING OF PSORIATIC ARTHRITIS (PSA): RESULTS FROM A REAL-WORLD SURVEY IN THE US AND EUROPE
Alexis Ogdie(University of Pennsylvania), Laura C. Coates(Nuffield Orthopaedic Centre), Oliver Howell(Adelphi Group (United Kingdom)), Sara Bruce Wirta(Novartis (Switzerland)), S. D. Chakravarty(Janssen (United States)), A Schubert, Steve Peterson(Janssen (United States)), Lihi Eder(Women's College Hospital), Nicola Booth(Manchester University NHS Foundation Trust), William Tillett(Royal United Hospital Bath NHS Trust)
Cited by 0
Related Papers
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis
|Arthritis & Rheumatology|2016|904
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021
|Nature Reviews Rheumatology|2022|575
Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial
|The Lancet|2015|477
International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials
|Annals of the Rheumatic Diseases|2016|275